Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study

Keyphrases

• Quetiapine 100%
• Treatment-resistant Obsessive-compulsive Disorder 100%
• Treatment Study 100%
• Placebo 50%
• Adjunct Therapy 16%
• Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) 16%
• Obsessive-compulsive Disorder 16%
• Second-generation Antipsychotics 16%
• Adult Treatment 16%
• Statistical Significance 16%
• Tolerability 16%
• Selective Serotonin Reuptake Inhibitors 16%
• Clinical Response 16%
• Spectrum Disorder 16%
• Comorbidity 16%
• Treatment Group 16%
• Premature Dropout 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Quetiapine 100%
• Obsessive Compulsive Disorder 100%
• Placebo 50%
• Tic 16%
• Prematurity 16%
• Disease 16%
• Typical Antipsychotic 16%
• Tolerability 16%
• Serotonin Reuptake Inhibitor 16%
• Comorbidity 16%
• Selective Serotonin Reuptake Inhibitor 16%

Neuroscience

• Quetiapine 100%
• Obsessive-Compulsive Disorder 100%
• Placebo 50%
• Serotonin Reuptake Inhibitor 16%
• Tic Disorder 16%
• Comorbidity 16%
• Typical Antipsychotic 16%
• Spectrum Disorder 16%
• Selective Serotonin Reuptake Inhibitor 16%